Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The FDA announced its draft guidance on recommendations for studies assessing pulse oximeters to ensure the devices perform ...

Draft recommendations from the FDA call for larger, more inclusive studies to ensure pulse oximeters work for people with ...

These devices, crucial for measuring blood oxygen levels, have shown discrepancies in accuracy when used on darker skin, leading to potential health risks for non-white patients, the study states ...

Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance ...

Pulse oximeters helped drive racial inequities in care during the pandemic, but many devices at drugstores and online won’t ...

The U.S. Food and Drug Administration on Jan. 6 issued new draft guidance to help improve the accuracy and performance of pulse oximeters that are used for medical purposes across populations with a r ...

There was "low but improving uptake" of reporting about the diversity of participants in summary documents for FDA-cleared ...

Pulse oximetry is noninvasive ... are characteristic for repetitive breathing disturbance in patients with sleep apnea. It is regularly integrated into PSG and CRM. Several indices derived ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

The advantage of pulse oximeters and TcCO2 monitors ... non-predictive values are found with screening by oximetry for obstructive sleep apnea in children. 5 “Unlike the current SMA respiratory ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...